Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials

被引:0
|
作者
Paller, Amy S. [1 ]
Yosipovitch, Gil [2 ]
Tom, Wynnis L. [3 ,4 ]
Lebwohl, Mark [5 ]
Boguniewicz, Mark [6 ,7 ]
Call, Robert S. [8 ]
Eichenfield, Lawrence F. [3 ,4 ]
Forsha, Douglass W. [9 ]
Rees, William C. [10 ]
Simpson, Eric L. [11 ]
Gold, Linda F. Stein [12 ]
Zaenglein, Andrea L. [13 ]
Tallman, Anna M. [14 ]
Tan, Bill [14 ]
Hebert, Adelaide A. [15 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[3] Rady Childrens Hosp San Diego, San Diego, CA USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Natl Jewish Hlth, Denver, CO USA
[7] Univ Colorado, Sch Med, Denver, CO USA
[8] Clin Res Partners, Richmond, VA USA
[9] Jordan Valley Dermatol & Res Ctr, W Jordan, UT USA
[10] PI Coor Clin Res, Burke, VA USA
[11] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[12] Henry Ford Hlth Syst, Detroit, MI USA
[13] Penn State Univ, Hershey, PA USA
[14] Pfizer Inc, New York, NY USA
[15] Univ Texas Houston, Med Ctr, Houston, TX USA
关键词
D O I
10.1542/peds.142.1_MeetingAbstract.815
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
815
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Ruxolitinib cream rapidly decreases pruritus in atopic dermatitis: Pooled results from two phase 3 studies
    Blauvelt, Andrew
    Szepietowski, Jacek C.
    Papp, Kim
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB121 - AB121
  • [12] Reduced pruritus and signs of atopic dermatitis in phase 3 trials with a nonsteroidal topical phosphodiesterase inhibitor, crisaborole
    Hebert, A. A.
    Eichenfield, L.
    Lebwohl, M. G.
    Paller, A. S.
    Simpson, E. L.
    Tom, W. L.
    Zane, L. T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S49 - S49
  • [13] EARLY RELIEF OF CLINICAL SYMPTOMS AND THE IMPROVEMENT DURING THE MAINTENANCE PERIOD OF CHILDHOOD ATOPIC DERMATITIS: A MULTICENTER CLINICAL STUDY OF CRISABOROLE OINTMENT
    Wang, Shan
    Ma, Lin
    Shu, Hong
    Zhang, Bin
    Qian, Qiufang
    Li, Ping
    Wang, Hua
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 14 - 15
  • [14] Early improvement in pruritus and reduction in clinical signs in a phase 2a mechanism of action study of crisaborole in mild to moderate atopic dermatitis
    Bissonnette, R.
    Ports, W. C.
    Zang, C.
    Vranic, I.
    Werth, J. L.
    Purohit, V. S.
    Zielinski, M. A.
    Vlahos, B.
    Saint-Cyr-Proulx, E.
    Estrada, Y. D.
    Pavel, A. B.
    Guttman-Yassky, E.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 49 - 50
  • [15] Effects of ruxolitinib cream on pruritus and sleep in atopic dermatitis: 52-week pooled results from two phase III studies
    Simpson, E. L.
    Boguniewicz, M.
    Thaci, D.
    Misery, L.
    Armstrong, A. W.
    Silverberg, J. I.
    Venturanza, M. E.
    Kallender, H.
    Gao, J.
    Szepietowski, J. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E166 - E167
  • [16] Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trials
    Simpson, E. L.
    Rahawi, K.
    Hu, X.
    Chu, A. D.
    Nduaka, C.
    Jazayeri, S.
    Lio, P.
    Lynde, C.
    Schuttelaar, M. L. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1863 - 1870
  • [17] Efficacy and safety of ruxolitinib cream among adolescents with atopic dermatitis: Pooled Results from two phase 3 studies
    Eichenfield, Lawrence F.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Paller, Amy S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB158 - AB158
  • [18] A Novel Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor, Crisaborole Ointment, Reduced Pruritus and Signs of Atopic Dermatitis in 2 Phase 3 Studies in Children and Adults
    Hebert, Adelaide A.
    Eichenfield, Lawrence F.
    Lebwohl, Mark G.
    Paller, Amy S.
    Simpson, Eric L.
    Tom, Wynnis L.
    Hughes, Matilda H.
    Zane, Lee T.
    PEDIATRICS, 2018, 141
  • [19] Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kallender, Howard
    Sturm, Daniel
    Wang, Mingyue
    Eichenfield, Lawrence F.
    DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2139 - 2151
  • [20] Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis
    Paller, A. S.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (03) : 663 - 664